When renal function is impaired, renal clearance is decreased in proportion to that of creatinine and thus the elimination half-life is prolonged, leading to increased levels of metformin in plasma.
Dermed er eliminationshalveringstiden forlænget, hvilket fører til øgede plasmakoncentrationer af metformin.